SafeTest
SafeTest is a privately held Brazilian diagnostics company founded in 2016 in Belo Horizonte, focused on developing rapid methods for early detection of infectious diseases in human and animal health markets. No products or commercial details are publicly disclosed.
- Company typePrivate
- Founded2016
- HeadquartersBelo Horizonte, Brazil
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What SafeTest does
SafeTest is a privately held Brazilian health company founded in 2016 and headquartered in Belo Horizonte. According to its own positioning, the firm was created to address market demand for rapid and precise methods for early detection of infectious diseases, operating across both human and animal health verticals. Its public website (safetest.com.br) carries a brand promise of "Soluções Inovadoras em Saúde Humana e Animal" (Innovative Solutions in Human and Animal Health), but is currently in programmed maintenance mode, with no products, modules, technology descriptions, or service details publicly disclosed.
The company has not published technical documentation regarding assay platforms, detection chemistries, instrument requirements, or any underlying scientific methodology. No patents, trademarks, certifications, regulatory approvals (e.g., ANVISA registration), or compliance attestations appear in the available record. Similarly, no management team, headcount, customer logos, or distribution channels have been disclosed. The business model — including pricing, revenue mechanics, and go-to-market — is not articulated in the source data.
A single SEED-stage financing event is on record from January 2018, with the investor identity and round value unspecified (recorded as $0 in available data). No subsequent funding rounds, M&A activity, or corporate structural changes have been disclosed. The website's current maintenance state, combined with the absence of any post-2018 corporate signals, makes it difficult to verify whether the company is actively commercializing, operating in a low-visibility mode, or effectively inactive. The available evidence supports a description of SafeTest as a very early-stage, information-thin diagnostics entity in Brazil, with no verifiable commercial traction disclosed.
SafeTest firmographics
Firmographics- Name
- SafeTest
- Legal name
- SafeTest
- Website
- https://safetest.com.br
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- SafeTest is a privately held Brazilian diagnostics company founded in 2016 in Belo Horizonte, focused on developing rapid methods for early detection of infectious diseases in human and animal health markets. No products or commercial details are publicly disclosed.
- Ownership category
- akta.pro rank
SafeTest industry classification
Industry- Product category
- In-Vitro Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Veterinary Services (541940), Medical and Diagnostic Laboratories (62151)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Point-of-Care & In-Clinic Diagnostics (Rapid Tests, Benchtop Analyzers) (HLAMADAI)
- akta.pro secondary industries
- Veterinary Parasitology Testing (HLAMADAD), Notifiable Disease Reporting & Case Investigation (HLAJABAA)
Keywords
Where SafeTest is headquartered
LocationHeadquarters
- HQ city
- Belo Horizonte
- HQ country
- Brazil
- HQ region
- Latin America
Markets served
SafeTest business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Technology or R&D, Personnel, Supply Chain
SafeTest product offering
Product offeringCore offering
SafeTest develops solutions in human and animal health, with its creation driven by the market demand for rapid and precise methods for the early detection of infectious diseases. The company's website is currently under programmed maintenance, so specific product lines and technical specifications are not publicly disclosed at this time.
Product overview
SafeTest offers innovative solutions in human and animal health. The company website is currently under programmed maintenance, with a contact form available for inquiries. No specific product names, modules, or service details are publicly available due to the site being offline at the time of data collection.
Differentiator
Problem solved
Functional benefit
Companies that use SafeTest
Customer profileIdeal customer profiles1 record
SafeTest technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
SafeTest partnerships and signals
Strategic signalRecent moves3 records
SafeTest competitors and assessment
Company assessmentBroad incumbents
- Cepheid (Danaher): Developer of the GeneXpert rapid molecular diagnostics platform, widely used for infectious disease testing globally; directly comparable to SafeTest in the rapid infectious disease diagnostics category.
- bioMérieux: Global leader in in vitro diagnostics with deep menus for infectious disease detection (e.g., BioFire, VITEK); comparable to SafeTest on product category (rapid infectious disease diagnostics) and end customers, though operating at vastly greater scale.
- Roche Diagnostics: Global diagnostics leader with cobas molecular and immunoassay systems for infectious disease; comparable product overlap with SafeTest in rapid and precise infectious disease detection.
- Abbott Diagnostics: Global diagnostics incumbent with rapid molecular and immunoassay platforms (e.g., ID NOW, Binax) targeting infectious disease; comparable to SafeTest in rapid infectious disease testing, though as a multi-billion-dollar diversified player.
Emerging players
- SD Biosensor: Korean-origin diagnostics company with a strong portfolio of rapid antigen and molecular infectious disease tests; comparable to SafeTest as a focused, non-incumbent rapid-test specialist competing in the same category.
- Mologic: Developer of rapid lateral-flow and immunoassay diagnostics for infectious and neglected tropical diseases; comparable to SafeTest in technology category (rapid diagnostics for infectious disease) and target use cases.
Direct peers
- Celer Biotecnologia: Brazilian veterinary diagnostics company producing rapid test kits for animal infectious diseases (including livestock and companion animals); directly comparable to SafeTest's animal-health rapid-test positioning.
- Gold Analisa Diagnóstica: Brazilian diagnostics company offering clinical chemistry, immunoassay, and infectious disease test kits; comparable to SafeTest as a domestic supplier of human-health diagnostic products serving Brazilian labs and hospitals.
- WAMA Diagnóstica: Brazil-based in vitro diagnostics manufacturer producing rapid tests and immunoassays for infectious diseases across human and veterinary markets; directly comparable to SafeTest in geography, product category, and customer base.
Regional players
- Fundação Ezequiel Dias (FUNED): Minas Gerais state public health laboratory that produces and supplies diagnostic kits (including for infectious diseases); comparable to SafeTest as a Brazil-based infectious-disease diagnostics provider, though operating as a public-sector entity.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks4 records
Key highlights3 records
Customer concentration
SafeTest social profiles
Digital presenceSafeTest financial estimates
Financial estimateRevenue estimate
Valuation estimate
SafeTest leadership team
Management profileNumber of profiles
SafeTest funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SafeTest M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SafeTest
What does SafeTest do?
SafeTest develops solutions in human and animal health, with its creation driven by the market demand for rapid and precise methods for the early detection of infectious diseases. The company's website is currently under programmed maintenance, so specific product lines and technical specifications are not publicly disclosed at this time.
Is SafeTest a public or private company?
SafeTest is a private company. It is classified as venture growth investor backed and is currently operating.
When was SafeTest founded?
SafeTest was founded in 2016. It employs 1 to 10 people.
Where is SafeTest based?
SafeTest is headquartered in Belo Horizonte, Brazil, in the Latin America region.
Who are SafeTest's main competitors?
Broad incumbents on record are Cepheid (Danaher), bioMérieux, Roche Diagnostics and Abbott Diagnostics. Emerging players are SD Biosensor and Mologic. Direct peers are Celer Biotecnologia, Gold Analisa Diagnóstica and WAMA Diagnóstica. Fundação Ezequiel Dias (FUNED) is listed as a regional player.
Does SafeTest have an API?
No public API is recorded for SafeTest.
What industry is SafeTest in?
SafeTest's product category is In-Vitro Diagnostics. Its primary akta.pro industry code is HLAMADAI, Point-of-Care & In-Clinic Diagnostics (Rapid Tests, Benchtop Analyzers), with a secondary code of HLAMADAD, Veterinary Parasitology Testing. Its NAICS code is 325413 and its SIC code is 2835.